About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,685 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,685 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 901-920 of 13,685 trials

CompletedAlternatives for Reducing Chorea in Huntington DiseaseThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of SD-809 extended release (ER) in participants switching from tetrabenazine to SD-809 ER.NCT01897896·Birmingham, Alabama and 37 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedA Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.NCT03832946·Andalusia, Alabama and 127 others

CompletedPegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)Infection with both HIV and hepatitis C virus (HCV) may result in serious and sometimes fatal liver disease.NCT00078403·Birmingham, Alabama and 36 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

CompletedCarisbamate in Adult & Pediatric Subjects With Lennox-Gastaut SyndromeThis is an open-label, multi-center study of carisbamate in adult and pediatric subjects with LGS, with single- and multiple-dose PK assessments from Days 1 through 73.NCT03731715·Baltimore, Maryland and 6 others

CompletedFlublok or Fluzone With Advax-CpG55.2 or AF03This is a Phase I, randomized, double blinded, clinical trial in up to 240 males and non-pregnant females, 18-45 years of age, inclusive, who are in good health and meet all…NCT03945825·Atlanta, Georgia and 7 others

TerminatedOptimal Treatment for Recurrent Clostridium DifficileThe purpose of this study is to determine whether fidaxomicin and vancomycin followed by taper and pulse vancomycin treatment are superior to standard vancomycin treatment for the…NCT02667418·Phoenix, Arizona and 32 others

CompletedAn Extension Study to Determine the Efficacy and Safety of STI571 in Participants With Chronic Myeloid Leukemia Who Are Refractory to or Intolerant of Interferon-AlphaDuring the Core Phase of the study, participants received STI571 at a dose of 400 milligrams (mg) daily for up to 12 months.NCT00171223·Los Angeles, California and 27 others

CompletedPyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma MultiformeRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006355·Birmingham, Alabama and 7 others

CompletedA Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)The purpose of this phase 3, randomized, multicenter study is to compare VB-111 and paclitaxel to placebo and paclitaxel in adult patients with Recurrent Platinum-Resistant…NCT03398655·Birmingham, Alabama and 93 others

Active not recruitingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneThis phase II trial studies the effects of the combination of olaparib and durvalumab, cediranib and durvalumab, olaparib and capivasertib, and cediranib alone in treating…NCT03660826·Birmingham, Alabama and 760 others

CompletedSafety and Diagnostic Efficacy of Mangoral in Participants With Focal Liver Lesions and Reduced Kidney FunctionThe overall objective of this study is to evaluate the safety and diagnostic efficacy of Mangoral in liver MRI in participants with known or suspected focal liver lesions and…NCT04119843·Scottsdale, Arizona and 59 others

CompletedLung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching BiomarkersThis phase II trial studies how well durvalumab works in treating patients with stage IV squamous cell lung cancer that has come back after previous treatment.NCT02766335·Birmingham, Alabama and 992 others

RecruitingCabotegravir-Hormone PK/PD Interactions for HIV PreventionThis is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people.NCT07672717·Baltimore, Maryland

CompletedPhase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasThis is a phase II open label study that will evaluate children ≥ 1 year of age and adults with neurofibromatosis type 1 (NF1) and plexiform neurofibromas treated with the MEK…NCT03231306·Birmingham, Alabama and 21 others

CompletedLong-Term Effects of HIV Exposure and Infection in ChildrenAs new drugs and vaccines are developed to prevent HIV disease progression and prolong survival of HIV infected patients, the short-term safety and effectiveness of these…NCT00006304·Birmingham, Alabama and 91 others

CompletedQUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerThis is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo plus gemcitabine as first-line treatment of subjects with metastatic pancreatic cancer.NCT00630552·Alhambra, California and 43 others

RecruitingInvestigation on the Bidirectional Cortical Neuroprosthetic SystemThe Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient…NCT03161067·Baltimore, Maryland

RecruitingA Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesThe goal of this clinical trial is to learn about the effect of the study drug (ZT-01) on low blood sugar (hypoglycemia) in adults with type 1 diabetes (T1D) who have been having…NCT05762107·Birmingham, Alabama and 45 others

RecruitingPivotal Study of N-acetyl-L-leucine for CACNA1AA pivotal, randomized, double-blind, placebo-controlled, multi-center therapeutic study for patients age 4 and older with a confirmed diagnosis of CACNA1A.NCT07221292·Baltimore, Maryland and 10 others

PreviousPage 46 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore